Literature DB >> 33446903

Role of dietitian support in improving weight loss and nutrition impact symptoms after oesophageal cancer surgery.

Poorna Anandavadivelan1, Anna Wikman2, Kalle Mälberg3, Helen Rosenlund3,4, Asif Johar3, Pernilla Lagergren3,5.   

Abstract

BACKGROUND: Oesophageal cancer is frequently accompanied with malnutrition. We aimed to evaluate if early support from dietitians and patient's level of satisfaction with the support from dietitians are associated with better outcomes for weight loss and nutrition impact symptoms (NIS).
METHODS: A nationwide and prospective cohort study on patients operated for oesophageal cancer in Sweden from 2013 onwards, included one year after surgery. Study exposures were (1) preoperative dietitian support (yes vs no) and, (2) patient reported satisfaction with dietitian support (high vs low) and outcomes were postoperative (1) percentage weight loss and (2) NIS score (range 0-24); one year after surgery. An ANCOVA model adjusted for predefined confounders was used and presented as mean differences (MD) with 95% confidence intervals (CI).
RESULTS: Among 245 patients, as many as 57% had received preoperative dietitian support. Preoperative dietitian support was not associated with statistically significant differences in mean postoperative weight loss (MD 0.2 [95% CI -2.6 to 2.9]) and mean NIS score (MD 0.1 [95% CI: -0.8 to 1.0]). Likewise, satisfaction with the dietitian support was not associated with significant differences in mean postoperative weight loss (MD 1.4 [95% CI: -1.5 to 4.3]) and NIS score (MD -0.1 [95% CI: -1 to 0.8]).
CONCLUSIONS: Long-term postoperative weight loss and NIS were not influenced based on whether dietitian support was initiated preoperatively or not and patient's satisfaction level with dietitian support. Similarity in results may reflect effective screening of malnutrition and dietitian support in centres treating oesophageal cancer in Sweden.

Entities:  

Year:  2021        PMID: 33446903     DOI: 10.1038/s41430-020-00830-0

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  16 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Quality of life and persisting symptoms after oesophageal cancer surgery.

Authors:  Pernilla Viklund; Yvonne Wengström; Ioannis Rouvelas; Mats Lindblad; Jesper Lagergren
Journal:  Eur J Cancer       Date:  2006-06-05       Impact factor: 9.162

3.  A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC.

Authors:  Frederick L Greene; Leslie H Sobin
Journal:  J Surg Oncol       Date:  2009-04-01       Impact factor: 3.454

4.  An investigation into the current peri-operative nutritional management of oesophageal carcinoma patients in major carcinoma centres in England.

Authors:  P M Murphy; P Modi; J Rahamim; T Wheatley; S J Lewis
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

Review 5.  Oesophageal cancer.

Authors:  Jesper Lagergren; Elizabeth Smyth; David Cunningham; Pernilla Lagergren
Journal:  Lancet       Date:  2017-06-22       Impact factor: 79.321

Review 6.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

7.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Authors:  Joel Shapiro; J Jan B van Lanschot; Maarten C C M Hulshof; Pieter van Hagen; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W Ten Kate; Geert-Jan M Creemers; Cornelis J A Punt; John Th M Plukker; Henk M W Verheul; Ernst J Spillenaar Bilgen; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  Lancet Oncol       Date:  2015-08-05       Impact factor: 41.316

8.  Malnutrition after oesophageal cancer surgery in Sweden.

Authors:  L Martin; J Lagergren; M Lindblad; I Rouvelas; P Lagergren
Journal:  Br J Surg       Date:  2007-12       Impact factor: 6.939

9.  Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome.

Authors:  Antoine Adenis; Emmanuelle Tresch; Sylvain Dewas; Olivier Romano; Mathieu Messager; Eric Amela; Stéphanie Clisant; Andrew Kramar; Christophe Mariette; Xavier Mirabel
Journal:  BMC Cancer       Date:  2013-09-06       Impact factor: 4.430

10.  Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case-control study.

Authors:  Aurelius Omlin; David Blum; Jan Wierecky; Sarah R Haile; Faith D Ottery; Florian Strasser
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-01-11       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.